Comment on: Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistantStreptococcus pneumoniae: analysis of Phase 3 clinical trial data
2015 ◽
Vol 70
(11)
◽
pp. 3170.1-3170
◽
Keyword(s):
Phase 3
◽
2014 ◽
Vol 69
(10)
◽
pp. 2835-2840
◽
2017 ◽
Vol 11
(suppl_1)
◽
pp. S301-S302
1981 ◽
Vol 9
(4)
◽
pp. 274-276
◽
1999 ◽
Vol 4
(12)
◽
pp. 794-800
◽
2013 ◽
Vol 19
(3)
◽
pp. 486-494
◽
2020 ◽
Vol 54
(9)
◽
pp. 939-940
◽
Keyword(s):